As on Thursday, Zimmer Biomet Holdings Inc (NYSE: ZBH) started slowly as it slid -0.16% to $127.52, before settling in for the price of $127.72 at the close. Taking a more long-term approach, ZBH posted a 52-week range of $102.00-$149.25.
Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '24.
Small-cap Uranium stocks are booming in 2024! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!
Get the FREE Report with all the details here.
Sponsored
In the past 5-years timespan, the Healthcare sector firm’s annual sales growth was -1.20%. Nevertheless, stock’s Earnings Per Share (EPS) this year is 6.80%. This publicly-traded company’s shares outstanding now amounts to $205.60 million, simultaneously with a float of $204.81 million. The organization now has a market capitalization sitting at $26.15 billion. At the time of writing, stock’s 50-day Moving Average stood at $126.69, while the 200-day Moving Average is $121.92.
Zimmer Biomet Holdings Inc (ZBH) Ownership Facts and Figures
Another important factor to analyze is how key investors are playing towards the stock of the Medical Devices industry. Zimmer Biomet Holdings Inc’s current insider ownership accounts for 0.13%, in contrast to 91.06% institutional ownership. According to the most recent insider trade that took place on Mar 07 ’24, this organization’s Group President, Asia Pacific sold 1,705 shares at the rate of 126.86, making the entire transaction reach 216,296 in total value, affecting insider ownership by 18,179. Preceding that transaction, on Feb 22 ’24, Company’s Sr. VP/Gen Counsel/Secretary sold 26,156 for 128.62, making the whole transaction’s value amount to 3,364,126. This particular insider is now the holder of 44,145 in total.
Zimmer Biomet Holdings Inc (ZBH) Earnings and Revenue Records
If we go through the results of last quarter, which was made public on 12/30/2023, the company posted $2.2 earnings per share (EPS) for the quarter, besting the agreed prediction (set at $2.15) by $0.05. Wall Street market experts anticipate that the next fiscal year will bring earnings of 2.02 per share during the current fiscal year.
Zimmer Biomet Holdings Inc’s EPS increase for this current 12-month fiscal period is 6.80% and is forecasted to reach 8.69 in the upcoming year.
Zimmer Biomet Holdings Inc (NYSE: ZBH) Trading Performance Indicators
Let’s observe the current performance indicators for Zimmer Biomet Holdings Inc (ZBH). It’s Quick Ratio in the last reported quarter now stands at 0.78. The Stock has managed to achieve an average true range (ATR) of 2.17. Alongside those numbers, its PE Ratio stands at $26.09, and its Beta score is 1.03. Another valuable indicator worth pondering is a publicly-traded company’s price to sales ratio for trailing twelve months, which is currently 3.54. Similarly, its price to free cash flow for trailing twelve months is now 26.72.
In the same vein, ZBH’s Diluted EPS (Earnings per Share) trailing twelve months is recorded 4.89, a figure that is expected to reach 1.88 in the next quarter, and analysts are predicting that it will be 8.69 at the market close of one year from today.
Technical Analysis of Zimmer Biomet Holdings Inc (ZBH)
Through scrutinizing the latest numbers posted by the [Zimmer Biomet Holdings Inc, ZBH], it can be observed that its last 5-days Average volume of 1.0 million was lower the volume of 1.49 million, it posted the year before. During the previous 9 days, stock’s Stochastic %D was recorded 29.09% While, its Average True Range was 2.18.
Raw Stochastic average of Zimmer Biomet Holdings Inc (ZBH) in the period of the previous 100 days is set at 72.93%, which indicates a major rise in contrast to 20.45% during the last 2-weeks. If we go through the volatility metrics of the stock, In the past 14-days, Company’s historic volatility was 22.93% that was higher than 17.38% volatility it exhibited in the past 100-days period.
